The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical response, progression-free survival (PFS), and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) vs IPI monotherapy in CheckMate 069 study.
 
F. Stephen Hodi
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Michael Andrew Postow
Consulting or Advisory Role - Amgen; Bioconnections LLC; FirstWord; Millennium
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jason Alan Chesney
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Anna C. Pavlick
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
 
Kenneth F. Grossmann
No Relationships to Disclose
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
Gerald P. Linette
No Relationships to Disclose
 
Nicolas Meyer
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Expert Testimony - Amgen; Bristol-Myers Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Jeffrey K. Giguere
No Relationships to Disclose
 
Sanjiv S. Agarwala
No Relationships to Disclose
 
Montaser F. Shaheen
No Relationships to Disclose
 
Marc S. Ernstoff
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - Alkermes (Inst); Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); ImmuNext (Inst); Johnson & Johnson (Inst); Merck (Inst); Polynoma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
David R. Minor
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
 
April Salama
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Merck
 
Matthew Hiram Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celldex; Eisai; Merck; Merck KGaA; Novartis
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; Bristol-Myers Squibb; MedImmune; Merck
 
Christine E. Horak
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Paul Gagnier
No Relationships to Disclose
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Honoraria - EMD Serono; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb